DK0687181T3 - Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling - Google Patents

Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling

Info

Publication number
DK0687181T3
DK0687181T3 DK94910226T DK94910226T DK0687181T3 DK 0687181 T3 DK0687181 T3 DK 0687181T3 DK 94910226 T DK94910226 T DK 94910226T DK 94910226 T DK94910226 T DK 94910226T DK 0687181 T3 DK0687181 T3 DK 0687181T3
Authority
DK
Denmark
Prior art keywords
individuals
respond
treating hepatitis
interferon therapy
hepatitis
Prior art date
Application number
DK94910226T
Other languages
Danish (da)
English (en)
Inventor
Paul B Chretien
Milton Mutchnick
Original Assignee
Alpha 1 Biomedicals Inc
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/027,500 external-priority patent/US6001799A/en
Application filed by Alpha 1 Biomedicals Inc, Univ Wayne State filed Critical Alpha 1 Biomedicals Inc
Application granted granted Critical
Publication of DK0687181T3 publication Critical patent/DK0687181T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2292Thymosin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK94910226T 1993-03-05 1994-03-03 Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling DK0687181T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/027,500 US6001799A (en) 1991-09-13 1993-03-05 Method of treating hepatitis C in non-responders to interferon treatment
PCT/US1994/002320 WO1994020131A1 (en) 1993-03-05 1994-03-03 Method of treating hepatitis c in non-responders to interferon treatment

Publications (1)

Publication Number Publication Date
DK0687181T3 true DK0687181T3 (da) 2001-10-01

Family

ID=21838079

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94910226T DK0687181T3 (da) 1993-03-05 1994-03-03 Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling

Country Status (17)

Country Link
EP (1) EP0687181B1 (pt)
JP (1) JPH06279309A (pt)
KR (1) KR100306024B1 (pt)
CN (1) CN1072961C (pt)
AT (1) ATE204760T1 (pt)
AU (1) AU683248B2 (pt)
CA (1) CA2157479C (pt)
DE (1) DE69428112T2 (pt)
DK (1) DK0687181T3 (pt)
ES (1) ES2162862T3 (pt)
FI (1) FI954127A (pt)
GR (1) GR3037021T3 (pt)
MY (1) MY121198A (pt)
NO (1) NO320877B1 (pt)
PT (1) PT687181E (pt)
SG (1) SG64894A1 (pt)
WO (1) WO1994020131A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016204A1 (en) 1995-11-02 1997-05-09 Schering Corporation Continuous low-dose cytokine infusion therapy
US7208167B2 (en) 2000-08-07 2007-04-24 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis C with thymosin and peptide combination therapy
EP1311286B1 (en) * 2000-08-07 2006-07-12 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis c with thymosin and pegylated interferon
EA008037B1 (ru) 2003-03-28 2007-02-27 Сциклон Фармасьютикалс, Инк. ЛЕЧЕНИЕ ИНФЕКЦИЙ, ВЫЗЫВАЕМЫХ ГРИБАМИ p. ASPERGILLUS, С ПОМОЩЬЮ ТИМОЗИНА АЛЬФА 1
CA2649063C (en) * 2006-05-02 2014-11-25 Luigina Romani Use of thymosin .alpha.1, alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection
US9034837B2 (en) * 2009-04-24 2015-05-19 Roche Innovation Center Copenhagen A/S Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon
ES2537785T3 (es) 2009-05-08 2015-06-12 Sciclone Pharmaceuticals, Inc. Péptidos de alfa timosina como potenciadores de vacunas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216056B (it) * 1988-03-11 1990-02-22 Sclavo Spa Composizioni farmaceutiche contenenti timosina alfa 1.
TW224053B (pt) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
CA2157479C (en) 2000-08-08
NO953473D0 (no) 1995-09-04
CN1072961C (zh) 2001-10-17
DE69428112D1 (de) 2001-10-04
SG64894A1 (en) 1999-05-25
FI954127A0 (fi) 1995-09-04
KR100306024B1 (ko) 2001-11-30
NO320877B1 (no) 2006-02-06
CN1092322A (zh) 1994-09-21
KR960700741A (ko) 1996-02-24
FI954127A (fi) 1995-09-04
ATE204760T1 (de) 2001-09-15
JPH06279309A (ja) 1994-10-04
CA2157479A1 (en) 1994-09-15
MY121198A (en) 2006-01-28
DE69428112T2 (de) 2002-03-21
AU6275994A (en) 1994-09-26
AU683248B2 (en) 1997-11-06
PT687181E (pt) 2002-01-30
ES2162862T3 (es) 2002-01-16
NO953473L (no) 1995-09-04
EP0687181B1 (en) 2001-08-29
EP0687181A1 (en) 1995-12-20
GR3037021T3 (en) 2002-01-31
WO1994020131A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
DE60142776D1 (de) Behandlung von herpes infektion mit anwendung von immunomodulatore polynukleotide sequenzen
ES2103966T3 (es) Uso de una timosina en el tratamiento de hepatitis c.
WO2001068077A3 (en) Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
DE69636734D1 (de) Nucleoside mit anti-hepatitis b virus wirksamkeit
DE69233607D1 (de) Peptide, die die zytotoxische T-Lymphozyte Antwort gegen Hepatitis-B-Virus induzieren
DK0687181T3 (da) Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
AR036697A1 (es) Metodo para el tratamiento de la infeccion por virus de hepatitis c en pacientes sin respuesta a tratamiento
BR9913951A (pt) Tratamento de infecção de hepatite b com timosina alfa 1 em combinação com lamivudina e flamciclovir
CY1106388T1 (el) Θepαπεια ηπατιτιδας c με θυμοσινη, ιντepφepονη και ριβαβιρινη
DK0531341T3 (da) Anvendelse af leukoregulin til behandling af dyr, der er inficeret med et kappevirus
NO930401D0 (no) Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav
DE60121449D1 (de) Behandlung von hepatitis c mit thymosin und pegyliertem interferon
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
BR112022006913A2 (pt) Métodos para tratar infecções virais de hepatite delta
MY101495A (en) Treatment of diseases caused by viruses